The views and opinions expressed are those of the contributing authors and editors and do not necessarily represent the views of the ACC.
A discussion with Drs. Rodney de Palma and Roger Corder.
Learn about the ‘troponinitis’ phenomenon, a scenario in which a high-sensitivity cardiac troponin immunoassay detects leaking troponin above the 99th percentile of a reference population in a patient not experiencing ACS.
The lead investigator of the ODESSEY alirocumab clinical trial reports superiority of Alirocumab versus ezetimibe.
An expert response from Dr. David Feldman and Dr. Seth Martin.
A review by Dr. Kasey Leger.
Which laboratory test is reasonable and can help guide further management of this patient's CV risk?
Interact and share with your colleagues biomarker topics that are relevant to you and your practice.
Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
Coronary Vessel Wall Contrast Enhancement Imaging as a Potential Direct Marker of Coronary Involvement: Integration of Findings From CAD and SLE Patients
Genotype Positive Status in Patients With Hypertrophic Cardiomyopathy Is Associated With Higher Rates of Heart Failure Events
© 2014 American College of Cardiology Foundation. Visit Cardiosource.
Terms & Conditions
Registered User Agreement
Advertising and Sponsorship Policy